Is the life-long entecavir treatment really inevitable in chronic hepatitis B patients?

With great interest, we read the manuscript "Long-term hepatitis B surface antigen (HBsAg) kinetics during entecavir treatment in Korean patients-functional cure unlikely" by Ju-Yeon Cho et al. published in Journal of Viral Hepatitis.